United States · FDA National Drug Code directory
Brimonidine Tartrate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71921-185_81960280-6045-44e8-a499-6f737a92c7f2
- Product NDC
- 71921-185
- Form
- SOLUTION/ DROPS
- Composition / generic term
- Brimonidine Tartrate
- Labeler
- Florida Pharmaceutical Products, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220115
- Source listing expiry
- 20271231
Source-listed ingredients
- BRIMONIDINE TARTRATE — 2 mg/mg
These values do not establish equivalence or a dose recommendation.
Packages
- 5 mg in 1 BOTTLE, PLASTIC (71921-185-05) · 71921-185-05
- 10 mg in 1 BOTTLE, PLASTIC (71921-185-10) · 71921-185-10
- 15 mg in 1 BOTTLE, PLASTIC (71921-185-15) · 71921-185-15
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →